Periodic Reporting for period 3 - PROTEUS (Predicting Routes Of Tumour Evolution driven by Unstable genomes and Selection)

Despite progress in cancer drug development, the majority of patients with advanced disease have poor prognoses due to cancer drug resistance. Poor outcome is a result of tumour genomic diversity, which increases the risk of acquiring drug resistance. Longitudinal clinical...